Authors: Yacobi, A Masson, E Moros, D Ganes, D Lapointe, C Abolfathi, Z LeBel, M Golander, Y Doepner, D Blumberg, T Cohen, Y Levitt, B

Citation: A. Yacobi et al., Who needs individual bioequivalence studies for narrow therapeutic index drugs? A case for warfarin, J CLIN PHAR, 40(8), 2000, pp. 826-835

Authors: Labbe, L Abolfathi, Z Robitaille, NM St-Maurice, F Gilbert, M Turgeon, J

Citation: L. Labbe et al., Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine, THER DRUG M, 21(2), 1999, pp. 191-199

Authors: Yacobi, A Zlotnick, S Colaizzi, JL Moros, D Masson, E Abolfathi, Z LeBel, M Mehta, R Golander, Y Levitt, B

Citation: A. Yacobi et al., A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: A case for carbamazepine, CLIN PHARM, 65(4), 1999, pp. 389-394